EP3904500A4 - Holdemanella sp. bacterium and use thereof - Google Patents

Holdemanella sp. bacterium and use thereof Download PDF

Info

Publication number
EP3904500A4
EP3904500A4 EP19902893.7A EP19902893A EP3904500A4 EP 3904500 A4 EP3904500 A4 EP 3904500A4 EP 19902893 A EP19902893 A EP 19902893A EP 3904500 A4 EP3904500 A4 EP 3904500A4
Authority
EP
European Patent Office
Prior art keywords
holdemanella
bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19902893.7A
Other languages
German (de)
French (fr)
Other versions
EP3904500A1 (en
Inventor
Yolanda Sanz Herranz
Inmaculada LÓPEZ ALMELA
Eva Mª GÓMEZ DEL PULGAR VILLANUEVA
Alfonso BENÍTEZ-PÁEZ
Marina ROMANÍ PÉREZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Publication of EP3904500A1 publication Critical patent/EP3904500A1/en
Publication of EP3904500A4 publication Critical patent/EP3904500A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19902893.7A 2018-12-26 2019-12-24 Holdemanella sp. bacterium and use thereof Pending EP3904500A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201831282A ES2769628B2 (en) 2018-12-26 2018-12-26 Holdemanella sp. and use of it
PCT/ES2019/070882 WO2020136301A1 (en) 2018-12-26 2019-12-24 Holdemanella sp. bacterium and use thereof

Publications (2)

Publication Number Publication Date
EP3904500A1 EP3904500A1 (en) 2021-11-03
EP3904500A4 true EP3904500A4 (en) 2022-09-28

Family

ID=71109043

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19902893.7A Pending EP3904500A4 (en) 2018-12-26 2019-12-24 Holdemanella sp. bacterium and use thereof

Country Status (7)

Country Link
US (1) US20220072064A1 (en)
EP (1) EP3904500A4 (en)
CN (1) CN113795572A (en)
CA (1) CA3124745A1 (en)
ES (1) ES2769628B2 (en)
MX (1) MX2021007889A (en)
WO (1) WO2020136301A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101590081A (en) * 2008-05-28 2009-12-02 青岛东海药业有限公司 Eubacterium ventriosum and Eubacterium biforme preparation and application thereof
CN104415060A (en) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 Edible composition as well as preparation method and application thereof
WO2016183577A1 (en) * 2015-05-14 2016-11-17 Crestovo Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940652B (en) * 2008-05-28 2015-03-25 青岛东海药业有限公司 Eubacterium biforme preparation and use thereof
ES2436251B1 (en) * 2012-05-25 2014-10-08 Consejo Superior De Investigaciones Científicas (Csic) BACTEROIDS CECT 7771 AND ITS USE IN THE PREVENTION AND TREATMENT OF OVERWEIGHT, OBESITY AND METABOLIC AND IMMUNOLOGICAL ALTERATIONS.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101590081A (en) * 2008-05-28 2009-12-02 青岛东海药业有限公司 Eubacterium ventriosum and Eubacterium biforme preparation and application thereof
CN104415060A (en) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 Edible composition as well as preparation method and application thereof
WO2016183577A1 (en) * 2015-05-14 2016-11-17 Crestovo Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ROMANÍ-PÉREZ MARINA ET AL: "Holdemanella biformis improves glucose tolerance and regulates GLP-1 signaling in obese mice", THE FASEB JOURNAL, vol. 35, no. 7, 18 June 2021 (2021-06-18), US, XP055953152, ISSN: 0892-6638, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1096/fj.202100126R> DOI: 10.1096/fj.202100126R *
See also references of WO2020136301A1 *
XU YOU-HUA ET AL: "Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice", JOURNAL OF ENDOCRINOLOGY, vol. 238, no. 3, 1 September 2018 (2018-09-01), pages 231 - 244, XP055953242, ISSN: 0022-0795, DOI: 10.1530/JOE-18-0137 *

Also Published As

Publication number Publication date
CA3124745A1 (en) 2020-07-02
ES2769628A1 (en) 2020-06-26
EP3904500A1 (en) 2021-11-03
MX2021007889A (en) 2021-09-08
US20220072064A1 (en) 2022-03-10
WO2020136301A8 (en) 2020-09-17
CN113795572A (en) 2021-12-14
WO2020136301A1 (en) 2020-07-02
ES2769628B2 (en) 2020-11-25

Similar Documents

Publication Publication Date Title
EP3763830A4 (en) Nanovesicles derived from lactobacillus sp. bacteria, and use thereof
EP3878863A4 (en) Anti-claudin18.2 antibody and use thereof
EP3794037A4 (en) Anti-claudin 18.2 antibodies and uses thereof
EP3762031A4 (en) Anti-claudin 18.2 antibodies and uses thereof
EP4041362A4 (en) Guidewire-management devices and methods thereof
EP3865568A4 (en) Akkermansia muciniphila strain and use thereof
EP3801065A4 (en) Designed bacterial compositions and uses thereof
EP3872093A4 (en) Anti-cldn18.2 antibody and uses thereof
EP3950716A4 (en) Anti-claudin 18.2 antibody and application thereof
EP3992209A4 (en) Cldn18.2 antibody and use thereof
EP4076448A4 (en) Fluoroalkyl-oxadiazoles and uses thereof
EP3781318A4 (en) Emulsifiers and the uses thereof
EP3805223A4 (en) 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof
EP3647437A4 (en) Nanovesicle derived from proteus genus bacteria, and use thereof
EP3750548A4 (en) Lipopolysaccharide-regulated enteric bacteria and use thereof
EP3800243A4 (en) Bacterium degrading las and/or n and use thereof
EP3902530A4 (en) Polymeric nanovaccines and uses thereof
EP3680331A4 (en) Modified cas9 protein, and use thereof
IL281171A (en) Cellulose-synthase-like enzymes and uses thereof
EP3654982A4 (en) 1,8-naphthyridinone compounds and uses thereof
EP3878956A4 (en) Modified cas9 protein, and use thereof
EP4245840A4 (en) Probiotic system and use thereof
EP3476932A4 (en) Novel sporichthyaceae microorganism and use thereof
EP3843736A4 (en) Isoquinoline-steroid conjugates and uses thereof
EP3715344A4 (en) 1,4-benzodiazapin-2-one derivatives and use thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210709

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220830

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/10 20060101ALI20220824BHEP

Ipc: A61P 3/08 20060101ALI20220824BHEP

Ipc: A61P 3/04 20060101ALI20220824BHEP

Ipc: A61K 35/74 20150101ALI20220824BHEP

Ipc: C12N 1/20 20060101AFI20220824BHEP